Comparison

CTSL/CAPN1-IN-2 European Partner

Item no. TMO-T86107-50mg
Manufacturer TargetMol
CASRN 2410075-64-6
Amount 50 mg
Quantity options 10 mg 10 mg 50 mg 50 mg
Category
Type Molecules
Specific against other
Smiles C(N[C@@H](CC1CCCCC1)C(N[C@@H](C[C@H]2C(=O)NCCC2)C(C(NCC3=CC=CC=C3)=O)=O)=O)(=O)C4=CC=5C(O4)=CC=CC5
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
Cysteine Protease|||SARS-CoV
Shipping Temperature
Cool pack
Storage Conditions
-20°C
Molecular Weight
600, 7
Description
CTSL/CAPN1-IN-2 (Compound 14b) serves as an orally active inhibitor targeting both CTSL and CAPN1, manifesting IC50 values of 6.88 nM for CTSL and 347.6 nM for CAPN1 respectively. This compound not only displays anti-inflammatory attributes but also features favorable pharmacokinetic properties. Moreover, CTSL/CAPN1-IN-2 shows extensive antiviral effects against coronaviruses by inhibiting viral entry [1].
Pathways
Proteases/Proteasome|||Microbiology/Virology

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close